IRIS
STELLA, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.173
EU - Europa 1.162
AS - Asia 819
SA - Sud America 290
AF - Africa 191
OC - Oceania 1
Totale 4.636
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.122
IT - Italia 571
SG - Singapore 411
BR - Brasile 274
IE - Irlanda 219
CN - Cina 206
CI - Costa d'Avorio 114
IN - India 92
UA - Ucraina 80
DE - Germania 79
SN - Senegal 56
RU - Federazione Russa 44
CA - Canada 43
VN - Vietnam 36
FI - Finlandia 31
BE - Belgio 22
SE - Svezia 22
GB - Regno Unito 21
KR - Corea 15
CZ - Repubblica Ceca 14
FR - Francia 14
TR - Turchia 10
IQ - Iraq 8
NG - Nigeria 8
AR - Argentina 7
BD - Bangladesh 7
CH - Svizzera 7
NL - Olanda 7
PL - Polonia 7
MA - Marocco 6
UZ - Uzbekistan 6
GR - Grecia 5
IL - Israele 5
AT - Austria 4
EC - Ecuador 4
ES - Italia 4
MX - Messico 4
NO - Norvegia 4
TN - Tunisia 4
HK - Hong Kong 3
IR - Iran 3
JP - Giappone 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
KZ - Kazakistan 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
ZA - Sudafrica 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
GL - Groenlandia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LT - Lituania 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 4.636
Salva come PNG Salva come JPEG
Città #
Santa Clara 508
Chandler 326
Singapore 269
Chicago 227
Dublin 219
Catania 143
Abidjan 114
Jacksonville 96
Boardman 84
Kochi 79
Ashburn 60
Cambridge 60
Lawrence 59
Dakar 56
Andover 55
Civitanova Marche 54
Grafing 35
Palermo 35
Nanjing 34
Des Moines 30
Wilmington 29
The Dalles 27
Dong Ket 26
Hefei 26
Toronto 24
Columbus 23
Brussels 22
Turku 22
Milan 21
Munich 19
Rome 19
Council Bluffs 18
Los Angeles 18
New York 17
São Paulo 17
Bari 15
Beijing 15
Seoul 14
Brno 13
San Mateo 13
Santa Venerina 12
Jiaxing 11
Messina 11
Nanchang 11
Ottawa 11
Falls Church 10
Seattle 10
Aci Catena 9
Belo Horizonte 9
Bremen 9
Hanoi 9
Saint Petersburg 9
Abuja 8
Curitiba 8
Hanover 7
Hebei 7
Pune 7
Redmond 7
Rio de Janeiro 7
Brasília 6
San Francisco 6
Scottsdale 6
Fairfield 5
Florence 5
Giardini-Naxos 5
Helsinki 5
Manaus 5
Mascalucia 5
San Giovanni la Punta 5
Shenyang 5
Belém 4
Boston 4
Casablanca 4
Changsha 4
Comiso 4
Cosenza 4
Edinburgh 4
Fantina 4
Frankfurt am Main 4
Grammichele 4
Juiz de Fora 4
Lappeenranta 4
Modica 4
Montreal 4
Redwood City 4
Ribeirão Preto 4
Siracusa 4
Arcugnano 3
Baghdad 3
Bedford 3
Brooklyn 3
Catanzaro 3
Florianópolis 3
Guarulhos 3
Jinan 3
London 3
Marília 3
Moscow 3
Nicolosi 3
Oslo 3
Totale 3.278
Salva come PNG Salva come JPEG
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 154
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 115
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily 107
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 103
Biomarkers and prognostic factors for malignant pleural mesothelioma 97
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 97
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 95
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 90
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 89
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 88
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 88
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 86
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 86
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 85
New insights in thyroid cancer and p53 family proteins 84
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 84
Double-face activity of resveratrol in voluntary runners: assessment of DNA damage by comet assay. 83
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 83
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 83
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 80
Uncommon long-term survival in a patient with chronic myeloid leukemia 79
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 79
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 78
Rufloxacin induced photosensitization in bio-models of increasing complexity 76
Suppression of survivin induced by BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs 76
Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions 75
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 74
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 73
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 73
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. 72
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 71
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report 71
Detection and clinical implications of a novel BCR-ABL1 E12A2 insertion/deletion in a CML patient expressing the E13A2 isoform 69
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 68
Opportunities and challenges of liquid biopsy in thyroid cancer 68
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 67
Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity 67
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 63
Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase 62
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report 62
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 62
Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors 61
THE ROLE OF SPARC IN CHRONIC MYELOID LEUKEMIA 60
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes 60
High BCR-ABL/GUS(IS) Levels at Diagnosis Are Associated with Unfavorable Responses to Standard Dose Imatinib 59
Roles of Interferon Regulatory Factors in Chronic Myeloid Leukemia 58
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 57
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study 57
Diagnosis of Chronic Myeloid Leukemia Early in Pregnancy 57
The Role of New Technologies in Myeloproliferative Neoplasms 57
Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma 57
Second-line dasatinib therapy improved compliance and deep molecular responses in imatinib-intolerant chronic myeloid leukemia patients 55
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 55
Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia 53
Hyperdiploidy associated with a high BCR-ABL transcript level may identify patients at risk of progression in chronic myeloid leukemia 52
A case of high-risk AML in a patient with advanced systemic mastocytosis 49
The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy 49
Approcci Terapeutici Innovativi per il Trattamento di Cellule di Leucemia Mieloide Cronica Resistenti ad Imatinib Mesilato 48
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 46
Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis 46
The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities 46
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance 44
Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes 42
Successful Nilotinib therapy in an imatinib-resistant chronic myeloid leukemia patient displaying an intron-derived insertion/truncation mutation in the BCR-ABL kinase domain 42
Personalized strategies for CML patients considering discontinuation of tyrosine kinase inhibitors treatment 41
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells 39
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 38
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients 32
Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer 31
REThinking the role of the RET oncogene in breast cancer 29
A Multiplex Assay for Fast PIK3CA Hotspot Mutation Characterization in a Single Specimen by 3-Color Digital PCR Analysis 25
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level 8
Totale 4.815
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.372
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021312 19 11 27 14 68 20 27 2 53 3 33 35
2021/2022435 20 67 11 7 78 8 64 15 25 11 30 99
2022/20231.036 68 82 56 119 58 148 13 201 209 14 46 22
2023/2024553 44 83 26 24 19 132 8 33 7 23 112 42
2024/20252.107 30 330 79 152 412 291 166 64 75 143 255 110
2025/202646 46 0 0 0 0 0 0 0 0 0 0 0
Totale 4.815